Tisagenlecleucel

Tisagenlecleucel, sold under the brand name Kymriah, is a CAR T cells medication for the treatment of B-cell acute lymphoblastic leukemia (ALL) which uses the body's own T cells to fight cancer (adoptive cell transfer).

Uses your system voice; voice and rate in settings.

≈ 2 min read

Cite, export and learn8 citation formats · 8 exports · lesson and quiz

Names in other languages

No names in other languages are held for this entry yet.

Article bodies are English and are not machine-translated. A name in another language is not a translation of the article.

Tisagenlecleucel, sold under the brand name Kymriah, is a CAR T cells medication for the treatment of B-cell acute lymphoblastic leukemia (ALL) which uses the body's own T cells to fight cancer (adoptive cell transfer). The most common serious side effects are cytokine release syndrome (a potentially life-threatening condition that can cause fever, vomiting, shortness of breath, pain and low blood pressure) and decreases in platelets (components that help the blood to clot), hemoglobin (the protein found in red blood cells that carries oxygen around the body) or white blood cells including neutrophils and lymphocytes.

T cells from a person with cancer are removed, genetically engineered to make a specific chimeric cell surface receptor with components from both a T-cell receptor and an antibody specific to a protein on the cancer cell, and transferred back to the person. The T cells are engineered to target a protein called CD19 that is common on B cells.

A chimeric T cell receptor ("CAR-T") is expressed on the surface of the T cell. The platform invented at the University of Pennsylvania was clinically developed by Novartis, including market authorization, and real world evidence. In August 2017, it became the first FDA-approved treatment that included a gene therapy step in the United States.

Text derived from https://en.wikipedia.org/w/index.php?oldid=1352194037 under CC BY-SA 4.0; modifications have been made.

Provenance

snapshot enwiki-001352194037 · captured 2026-05-02 · ledger · version history

Cite this page as: encyclopegia.org, “Tisagenlecleucel”, snapshot enwiki-001352194037. https://encyclopegia.org/a/tisagenlecleucel

Sources cited in this revision

20 named source(s) extracted from the cited revision. A source with no author is shown by its publication; nothing is invented.